📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review. (2020)

First Author: Furukawa TA

Attributed to: Clinical Psychopharmacology of Depression funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/acps.13145

PubMed Identifier: 31891415

Publication URI: http://europepmc.org/abstract/MED/31891415

Type: Journal Article/Review

Volume: 141

Parent Publication: Acta psychiatrica Scandinavica

Issue: 5

ISSN: 0001-690X